Ginwa Enterprise (Group) Inc. (600080.SS)

CNY 7.81

(0.51%)

Total Liabilities Summary of Ginwa Enterprise (Group) Inc.

  • Ginwa Enterprise (Group) Inc.'s latest annual total liabilities in 2023 was 470.12 Million CNY , up 61.75% from previous year.
  • Ginwa Enterprise (Group) Inc.'s latest quarterly total liabilities in 2024 Q2 was 289.31 Million CNY , up 6.04% from previous quarter.
  • Ginwa Enterprise (Group) Inc. reported annual total liabilities of 290.65 Million CNY in 2022, up 35.84% from previous year.
  • Ginwa Enterprise (Group) Inc. reported annual total liabilities of 213.97 Million CNY in 2021, down -9.81% from previous year.
  • Ginwa Enterprise (Group) Inc. reported quarterly total liabilities of 289.31 Million CNY for 2024 Q2, up 6.04% from previous quarter.
  • Ginwa Enterprise (Group) Inc. reported quarterly total liabilities of 340.08 Million CNY for 2024 Q3, up 17.55% from previous quarter.

Annual Total Liabilities Chart of Ginwa Enterprise (Group) Inc. (2023 - 1994)

Historical Annual Total Liabilities of Ginwa Enterprise (Group) Inc. (2023 - 1994)

Year Total Liabilities Total Liabilities Growth
2023 470.12 Million CNY 61.75%
2022 290.65 Million CNY 35.84%
2021 213.97 Million CNY -9.81%
2020 237.23 Million CNY -10.18%
2019 264.12 Million CNY 29.88%
2018 203.36 Million CNY -32.37%
2017 300.68 Million CNY -18.77%
2016 370.17 Million CNY 74.51%
2015 212.12 Million CNY -13.96%
2014 246.55 Million CNY 32.05%
2013 186.7 Million CNY 15.37%
2012 161.83 Million CNY 7.45%
2011 150.61 Million CNY -78.57%
2010 702.8 Million CNY 2.73%
2009 684.13 Million CNY 1.36%
2008 674.93 Million CNY -26.53%
2007 918.69 Million CNY -24.39%
2006 1.21 Billion CNY -19.3%
2005 1.5 Billion CNY 54.61%
2004 973.9 Million CNY 63.91%
2003 594.19 Million CNY 23.17%
2002 482.41 Million CNY 2.4%
2001 471.11 Million CNY 92.73%
2000 244.44 Million CNY 38.95%
1999 175.92 Million CNY 153.35%
1998 69.43 Million CNY 42.97%
1997 48.56 Million CNY -48.71%
1996 94.68 Million CNY 282.87%
1995 24.73 Million CNY 114.82%
1994 11.51 Million CNY 0.0%

Peer Total Liabilities Comparison of Ginwa Enterprise (Group) Inc.

Name Total Liabilities Total Liabilities Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 4.7 Billion CNY 90.003%
Yabao Pharmaceutical Group Co., Ltd 860.33 Million CNY 45.355%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 40.9 Billion CNY 98.851%
Harbin Pharmaceutical Group Co., Ltd. 8.37 Billion CNY 94.383%
Tasly Pharmaceutical Group Co., Ltd 3.86 Billion CNY 87.837%
Zhejiang Medicine Co., Ltd. 2.79 Billion CNY 83.169%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 3.49 Billion CNY 86.538%
Lionco Pharmaceutical Group Co.,Ltd. 693.51 Million CNY 32.212%
Humanwell Healthcare (Group) Co.,Ltd. 15.38 Billion CNY 96.945%
Joincare Pharmaceutical Group Industry Co.,Ltd. 13.34 Billion CNY 96.478%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 440.92 Million CNY -6.623%
China Animal Husbandry Industry Co., Ltd. 2.38 Billion CNY 80.275%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 299.24 Million CNY -57.101%
Zhejiang Huahai Pharmaceutical Co., Ltd. 10.34 Billion CNY 95.457%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.6 Billion CNY 70.691%
Ningbo Menovo Pharmaceutical Co., Ltd. 2.23 Billion CNY 78.992%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 2.2 Billion CNY 78.725%
Chongqing Taiji Industry(Group) Co.,Ltd 10.52 Billion CNY 95.534%
HPGC Renmintongtai Pharmaceutical Corporation 4.55 Billion CNY 89.677%
Nanjing Well Pharmaceutical Group Co.,Ltd. 686.22 Million CNY 31.491%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 2.24 Billion CNY 79.051%
Henan Lingrui Pharmaceutical Co., Ltd. 1.97 Billion CNY 76.175%
Shenzhen Chipscreen Biosciences Co., Ltd. 1.54 Billion CNY 69.474%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.47 Billion CNY 68.077%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 1.6 Billion CNY 70.776%
Zhongzhu Healthcare Holding Co.,Ltd 422.34 Million CNY -11.314%
Beijing Tongrentang Co., Ltd 9.67 Billion CNY 95.141%
KPC Pharmaceuticals, Inc. 3.9 Billion CNY 87.962%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 515.97 Million CNY 8.886%
North China Pharmaceutical Company Ltd. 14.68 Billion CNY 96.799%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 3.52 Billion CNY 86.667%
Tibet Weixinkang Medicine Co., Ltd. 436.54 Million CNY -7.691%
China National Medicines Corporation Ltd. 14.87 Billion CNY 96.839%
Zhejiang Hisun Pharmaceutical Co., Ltd. 9.26 Billion CNY 94.925%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 4.42 Billion CNY 89.376%
ChengDu ShengNuo Biotec Co.,Ltd. 431.06 Million CNY -9.06%
Dali Pharmaceuticalco.,Ltd 92.7 Million CNY -407.098%
Changchun BCHT Biotechnology Co. 1.01 Billion CNY 53.729%
Zhejiang Shengda Bio-Pharm Co., Ltd. 449.19 Million CNY -4.659%
Shanghai Jiaoda Onlly Co.,Ltd 475.91 Million CNY 1.217%
Jiang Zhong Pharmaceutical Co.,Ltd 1.6 Billion CNY 70.7%
Mayinglong Pharmaceutical Group Co., LTD. 959.61 Million CNY 51.009%
Cisen Pharmaceutical Co., Ltd. 1.57 Billion CNY 70.082%
Hunan Warrant Pharmaceutical Co.,Ltd 358.76 Million CNY -31.04%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 56.77 Billion CNY 99.172%
Jianmin Pharmaceutical Group Co.,Ltd. 1.89 Billion CNY 75.163%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.49 Billion CNY 68.496%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 3.38 Billion CNY 86.129%
Guobang Pharma Ltd. 2.92 Billion CNY 83.924%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 1.03 Billion CNY 54.437%
Kangmei Pharmaceutical Co., Ltd. 7.19 Billion CNY 93.47%
Shandong Buchang Pharmaceuticals Co., Ltd. 9.2 Billion CNY 94.892%
Zhejiang Starry Pharmaceutical Co.,Ltd. 3.66 Billion CNY 87.184%
Henan Taloph Pharmaceutical Stock Co.,Ltd 1.95 Billion CNY 75.894%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 1.65 Billion CNY 71.51%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 3.64 Billion CNY 87.117%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 805.75 Million CNY 41.654%
Shanghai Shyndec Pharmaceutical Co., Ltd. 4.89 Billion CNY 90.388%
Shanghai Yizhong Pharmaceutical Co., Ltd. 107.05 Million CNY -339.15%
Tibet Rhodiola Pharmaceutical Holding Co. 1.18 Billion CNY 60.423%
Sichuan Huiyu Pharmaceutical Co., Ltd. 886.91 Million CNY 46.993%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 696.15 Million CNY 32.468%
CanSino Biologics Inc. 3.86 Billion CNY 87.838%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 1.33 Billion CNY 64.874%
Shandong Lukang Pharmaceutical Co.,Ltd. 4.95 Billion CNY 90.503%